The dysregulation of microRNAs has recently been associated with cancer development
and progression in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions.
In solid pancreatic tumor tissue, the dysregulation of miR-146, miR-196a/b, miR-198, miR-
217, miR-409, and miR-490, as well as miR-1290 has been investigated in tumor biopsies of
patients with PDAC and was reported to predict cancer presence. However, the value of the
predictive biomarkers may further be increased during clinical conditions suggesting cancer …